Quanterix Corp (QTRX) research
Quanterix Corp- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $3.64
- As of
Quanterix Corp (QTRX): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-10.
As of . Source: SEC EDGAR filings for QTRX. Method and limitations.
Share the QTRX intelligence card
See the full QTRX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for QTRX on one page. Preview it with sample data, then open it live with a free account.
Preview the QTRX dossierActive signals for QTRX
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +142% to QTRX (2026Q2)
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 94% of QTRX (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +151% to QTRX (2026Q2)
- highINSTITUTIONAL_EXIT
D. E. Shaw & Co., Inc. cut 61% of QTRX (2026Q2)
- highCONSENSUS_BUY
3 tracked funds increased QTRX this 2026Q1 - institutional consensus
FREE, NO ACCOUNT
Every signal on QTRX, as it fires
You are seeing 5 of 14 signals recorded on QTRX since 2026-06-03.
The five above landed across 2 days. The other 9 were recorded on 2 other days. 8 of the 14 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in QTRX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 74766Q101 · 2026Q2 | $992K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 74766Q101 · 2026Q2 | $975K | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 74766Q101 · 2026Q2 | $176K | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 74766Q101 · 2026Q2 | $76K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, QTRX
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
QTRX against its peers
QTRX's operating margin of -90.4% ranks in the 37th percentile of 22 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | QTRX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 139M USD | 52.3M USD | 76 | 22 |
| Gross margin | 46.8% | 61.4% | 8 | 19 |
| Operating margin | -90.4% | -59.3% | 37 | 22 |
| Net margin | -77.1% | -67.1% | 41 | 22 |
| Return on equity | -36.2% | -70.9% | 73 | 19 |
Peers (23): EBRCZ, STIM, OWLT, ELMD, LUCD, INFU, TLSI, APYX, TMCI, LAB, ECOR, CATX, HYPR, CV, QSI, VMD, CLPT, LNSR, LUNG, RCEL, SERA, OFIX, ZOMDF. Left out: PROF (no annual filing), MOBI (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (QTRX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more QTRX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to QTRXand get the insider, 13F, options, and confluence read in one view.